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Flk1 is the major receptor for VEGF on endothelial cells. During embryogenesis, flk1 is required for both vasculogenesis and angiogenesis and
abnormally elevated flk1 expression is often associated with pathological conditions in adults. While the biological function of flk1 has been
studied extensively, very little is known about how the flk1 gene is regulated at the transcriptional level. Our transgenic study led to the
identification of a flk1 endothelial enhancer positioned approximately 5 kb upstream of the flk1 translation initiation site. Binding sites for FoxH1,
scl, ets and gata factors are found in the zebrafish flk1 endothelial enhancer, as well as in upstream sequences of mouse flk1 and human kdr genes,
suggesting that the regulatory machinery for flk1/kdr is conserved from fish to mammals. The roles of scl, ets and gata factors in hemangioblasts
have been well defined, but the significance of FoxH1 in vessel formation has not been explored previously. Here we show that FoxH1 binds to
the flk1 endothelial enhancer in vitro and functions as a repressor for flk1 transcription in cultured cells. Consistent with these findings, the
expression level of flk1 is elevated in embryos lacking both maternal and zygotic FoxH1. We further show that overexpression of FoxH1 has a
negative effect on vascular formation that can be counteracted by the down-regulation of smad2 activity in zebrafish embryos. Taken together, our
data provide the first evidence that flk1 is a direct target of FoxH1 and that FoxH1 is involved in vessel formation in zebrafish.
© 2007 Elsevier Inc. All rights reserved.Keywords: Angiogenesis; Blood vessel; FoxH1; flk1; ZebrafishIntroduction
A functional vascular system is required for the proper
development of vertebrate embryos and the survival of adults. A
number of signaling pathways, including VEGF and TGFβ,
have been shown to be involved in vascular formation, but the
VEGF pathway is the only one known to be involved in both
vasculogenesis (the formation of vessels from hemangioblasts)
and angiogenesis (the sprouting and remodeling of existing
vessels) (for review, see Roman and Weinstein, 2000).⁎ Corresponding author. Department of Molecular, Cell and Developmental
Biology, University of California, Los Angeles, CA 90095, USA.
E-mail address: chenjn@mcdb.ucla.edu (J.-N. Chen).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.01.023flk1 (also known as KDR and VEGFR2) is an endothelial-
specific receptor of vascular endothelial growth factor (VEGF).
During embryogenesis, flk1 expression is first detected in
hemangioblasts, the common precursor of the endothelial and
blood lineages, and remains active in endothelial cells during
vascular formation. Consistent with the importance of flk1 in
vessel formation, mouse embryos lacking flk1 do not have cells
from endothelial or hematopoietic lineages (Shalaby et al.,
1995). In zebrafish, embryos lacking the activity of the VEGF
receptor, flk1/kdra, display a partial loss of segmental arteries
(Habeck et al., 2002; Covassin et al., 2006). This mild
phenotype is likely to be the result of the compensatory effect
of a second flk1 homologue, kdrb. In fact, while kdrbmorphants
do not display apparent abnormalities in blood vessel formation,
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of segmental arteries (Covassin et al., 2006).
The expression of flk1 in endothelial cells is tightly regulated.
During embryogenesis, flk1 expression is down-regulated after
the vasculature is established. In adults, significant flk1
expression is only seen in tissues undergoing active angiogen-
esis, such as the mammary glands during pregnancy. Abnormal
elevation of flk1 expression is often associated with pathological
conditions, such as neovascularization in tumorigenesis (for
review, see Robinson and Stringer, 2001). The precise regulatory
circuit that regulates the expression of flk1 is not well
understood. However, the limited information available from
studies in the mouse model has revealed critical roles for scl, ets
and gata factors in flk1 regulation. Consensus binding sequences
of these transcription factors are found in the mouse flk1
enhancer and in the human KDR promoter (Patterson et al.,
1995; Kappel et al., 2000) and mutations in these transcription
factor binding sites abolish endothelial expression of the flk1
gene in the mouse model (Kappel et al., 2000; Elvert et al.,
2003). The regulatory relationship between flk1 and scl has also
been studied in the zebrafish. Overexpression of scl increases
flk1 expression in wild type embryos and can induce flk1
expression in the cloche mutant, which lacks endothelial and
blood cells (Liao et al., 1998, 2000), demonstrating that scl is an
important transcription factor that regulates flk1 gene expres-
sion. In addition, a recent study shows that overexpression of
Etsrp, an endothelial-specific Ets-1 related protein, induces
ectopic flk1 expression in wild type and clo mutant embryos
(Pham et al., 2006; Sumanas and Lin, 2006). These findings
suggest that the regulatory mechanisms of flk1 expression may
be conserved among vertebrates.
FoxH1 (also known as Fast1) is a forkhead transcription
factor that binds to Smad2/3 and mediates TGFβ signaling (for
review, see Attisano et al., 2001). Gene expression analysis
showed that FoxH1 is expressed primarily during early
developmental stages. Consistent with this finding, overexpres-
sion of FoxH1 induces the expression of a broad range of genes
downstream of activin and leads to abnormal axis formation in
Xenopus (Watanabe and Whitman, 1999). Furthermore, mouse
and zebrafish embryos carrying mutations in FoxH1 develop
gastrulation defects (Pogoda et al., 2000; Sirotkin et al., 2000;
Hoodless et al., 2001; Yamamoto et al., 2001). The roles for
FoxH1 at later developmental stages or in adults are not as clear.
However, the findings that FoxH1−/− mouse embryos do not
have the outflow tract or the right ventricle reveal a role of
FoxH1 in the formation of the anterior heart field (von Both et
al., 2004). Furthermore, the well-documented effects of TGFβ
signaling on the proliferation, differentiation, migration and
even survival of endothelial cells (for review, see Goumans and
Mummery, 2000; Goumans et al., 2003) suggest a role for
FoxH1 in the regulation of endothelial cells.
To further understand how the flk1 gene is regulated at the
transcriptional level in zebrafish, we systematically studied the
regulatory elements of flk1/kdra (hereafter referred to as flk1).
We identified an ∼6.4-kb genomic sequence upstream of the
translation initiation site of zebrafish flk1 that drives GFP
expression in the zebrafish vasculature, resembling the endo-genous flk1 expression pattern. Deletion analysis revealed that
an ∼800-bp DNA fragment positioned approximately 4.3 kb
upstream of the flk1 translation initiation site is sufficient to
drive flk1 expression in endothelial cells. Consensus sequences
of transcription factor binding sites including scl, ets and gata
factors are present in this 800 bp minimal flk1 enhancer
suggesting conserved regulatory machinery from fish to
mammals. In addition, we provide evidence that FoxH1 is part
of the regulatory machinery for flk1 gene expression in
zebrafish. We found multiple FoxH1 binding sites in the
upstream regulatory regions of zebrafish, mouse and human
flk1 genes. By gel shift assay, we show that FoxH1 binds to the
flk1 regulatory element. We further show that FoxH1 can repress
the activity of the flk1 minimal enhancer in HEK293T cells.
Consistent with this finding, the expression level of flk1 is
moderately elevated in zebrafish embryos lacking both maternal
and zygotic FoxH1 and overexpression of FoxH1 disrupts the
formation of zebrafish vasculature. Moreover, we showed that
flk1 gene expression is up-regulated in smad2 morphants and
that such changes in flk1 expression levels could be counteracted
by overexpression of FoxH1, indicating that the negative effects
of FoxH1 on flk1 gene expression is smad2 dependent. These
data suggest that FoxH1 functions as a negative modulator of
flk1 gene expression and indicate interplay between TGFβ and
VEGF signaling pathways in embryonic vascular formation.
Materials and methods
Zebrafish husbandry and the generation of TG(flk1:GFP)la116
transgenic lines
The AB strain was used for this study. Adult fish and embryos were
maintained as previously described (Westerfield, 2000).
An ∼6.4-kb genomic fragment upstream of the zebrafish flk1 gene (from
−6410 to −1 upstream of flk1 translational initiation site) was cloned into pKS-
GM2r vector 5′ to green fluorescent protein (GFP) (kind gift from S. Lin) to
create the flk(−6.4)-GFP construct. Approximately 50 pg of linearized flk
(−6.4)-GFP DNAwas microinjected into zebrafish embryos at the 1-cell stage.
The injected embryos were raised to adulthood and screened for founder fish
with germline integration. Images of GFP expression patterns of TG(flk1:
GFP)la116 embryos were acquired using a Zeiss SV-11 epifluorescence
microscope or an Olympus IX70 confocal microscope equipped with a 10×
objective.
Deletion constructs of flk(−6.4)-GFP
Serial deletion constructs of flk(−6.4)-GFP were generated using the
ERASE-A-BASE system (Promega). Sequencing analysis showed that flk
(−5.7)-GFP, flk(−5.0)-GFP, flk(−4.3)-GFP, flk(−3.5)-GFP and flk(−1.5)-GFP
have sequences upstream of flk1 translational initiation site starting from −5680,
−5016, −4353, −3565 and −1503, respectively. DNA fragments corresponding
to sequences from −5045 to −3543, −4353 to −3543 and −5045 to −4326 were
amplified by PCR using the following primers: −5045F, 5′-CCGCGGTTGTAT-
GAAGTTTCTGTGTGAC-3′; −4353F, 5′-CCGCGGTCACCTTCT GCTAGT-
TAAAACC-3′; −4326R, 5′-GCGGCCGCGAATGAGGTTTTAACTAG-
CAGA-3′; −3543R, 5′-GCGGCCGCAATCCAAAGTAATTGATCCCTG-3′.
These DNA fragments were then cloned into flk(−1.5)-GFP to create flk(−5.0,
−3.5/−1.5)-GFP, flk(−5.0, −4.3/−1.5)-GFP and flk(−4.3, −3.5/−1.5)-GFP.
Approximately 50 pg of each of these constructs were microinjected into
zebrafish embryos at the 1-cell stage. The injected embryos were screened for
transient expression of GFP using a Zeiss SV-11 epifluorescence microscope
after 1 day of development.
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mRNA encoding FoxH1 (kind gift from D. Meyer) (Pogoda et al., 2000),
FAST-Eng and FAST-VP16 (kind gifts from M. Whittman) (Watanabe and
Whitman, 1999) were synthesized using mMESSAGE mMACHINE (Ambion)
and injected into TG(flk1:GFP)la116 embryos at the 1- to 4-cell stage.
A morpholino modified oligonucleotide specifically targeting the translation
initiation site of smad2, smad2MO, was synthesized (GAGTGAAAGGCAA-
GATGGAGGACAT) (Genetools). 0.8 ng of smad2 morpholino was injected
into TG(flk1:GFP)la116 embryos at the 1- to 4-cell stage.
The vasculature of the FoxH1 mRNA or smad2MO-injected embryos was
analyzed at between the 18-somite stage and 24 hpf (hour post-fertilization).
Embryos were photographed using a Zeiss SV-11 epifluorescence microscope
and Axiocam digital camera and the intensity of GFP signals was quantified by
the NIH ImageJ program. The p value was calculated by the Student's t-test.
GST fusion proteins
The zebrafish FoxH1 cDNA (from D. Meyer) was cloned into the SmaI site
of pGEX-2TK (GE Healthcare) to create the pGEX-2TK-FoxH1 construct.
pGEX-2TK-FoxH1 and pGEX-2TK were transformed into BL21 (Stratagene).
The FoxH1-GST and GST proteins were purified using Bulk GST Purification
Module (GE Healthcare). Protein concentrations were determined using the DC
Protein Assay (Bio-Rad).Fig. 1. GFP expression in TG(flk1:GFP)la116 embryos. (A–D) GFP signals driven b
early as the 8-somite stage. flk1 expression is detected in three patches of cells by in si
Lateral views are shown in panels A and B and the dorsal views are shown in panels C
embryos at 24 hpf (F) resembles the flk1 pattern detected by in situ hybridization (E).
respectively. (I–L) GFP expression pattern of TG(flk1:GFP)la116 embryos at 48 h
magnification images of the head and trunk are shown in panels K and L, respective
brachial arches in 3-day-old TG(flk1:GFP)la116 embryos. (N–P) GFP expression
endothelial cells in the skin (N), gill (O) and gut (P).Electrophoretic mobility shift assays
Oligonucleotides corresponding to flk1 upstream sequences from −3870 to
−3844 were synthesized. Sequences of the upper strands are as follows: flk-
FoxH1, 5′-CCGAATATTGTGTATTCGAGAAATATC-3′, and flk-FoxH1-mt,
5′-CCGAATATTcTGTATTCGAGAAATATC-3′ (the FoxH1 binding sites are
underlined and the lowercase letter represents the substituted nucleotide).
Oligonucleotides were annealed in 20 mM Tris pH 8.0, 1 mM EDTA pH 8.0 and
50 mM NaCl.
Three micrograms of purified FoxH1-GST and GST proteins was incubated
with 32P end-labeled probes for 20 min at room temperature in binding buffer
containing 4% glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM
NaCl, 10 mM Tris–HCl (pH 7.5) and 0.05 mg/ml poly(dI-dC). Protein–DNA
complexes were separated on a 6% nondenaturating polyacrylamide gel (37.5:1
acrylamide/bis-acrylamide) in 0.5× TBE. Unlabeled flk-FoxH1 or flk-FoxH1-mt
were used as competitors at 50-, 100- or 200-fold molar excess of labeled probes.
Luciferase assay
FoxH1 cDNAwas subcloned into pSG5 (Stratagene) to create pSG5-FoxH1
expression vector and upstream sequences of flk1 from −532 to −371
containing predicted TATA box and transcription starting site were amplified
by PCR using flkP-F (5′-ACTGAGCGGCCGCTAGCCTGAATAAGTAGA-
TAGC-3′) and flkP-R (5′-CGGGATCCTACCTCTGACTTTTCTACTGG-3′).y the flk(6.4)-GFP transgene can be detected in TG(flk1:GFP)la116 embryos as
tu hybridization (A). A similar pattern is seen in TG(flk1:GFP)la116 embryos (B).
and D. Anterior to the left. (E–H) GFP expression pattern of TG(flk1:GFP)la116
Higher magnification images of the head and trunk are shown in panels G and H,
pf (J) resembles the flk1 pattern detected by in situ hybridization (I). Higher
ly. (M) Confocal image of GFP expression in endothelial cells in the brain and
remains active in adult TG(flk1:GFP)la116 fish. Images show GFP signals in
738 J. Choi et al. / Developmental Biology 304 (2007) 735–744The amplified DNA fragment was then cloned into a luciferase reporter
vector, pGL3-basic (Promega) to create the pGL3-flkP construct. Upstream
sequences of flk1 from −5045 to −3543 were amplified by PCR using the
−5045F and −3543R primers and cloned into pGL3-flkP to create pGL3-flk
(−5.0, −3.5)P. The Gs in all three FoxH1 consensus binding sequences were
substituted with Cs using QuikChange II Site-Directed Mutagenesis Kit
(Stratagene) to create the pGL3-flk(−5.0, −3.5)P-mt construct. Primers used for





CTGTAATCTAAAATTAT-3′; and mt3-R: 5′-ATAATTTTAGATTACAGATCT-
TCATTGGTATTTAA TG-3′.
HEK293T cells were plated on 24-well plates at a density of 50,000
cells per well and transfected using Lipofectamine™ and Plus™ reagents
(Invitrogen) with 0, 100 or 500 ng of pSG5-FoxH1, 10 ng of luciferase
reporter plasmid (pGL3-flk(−5.0, −3.5)P or pGL3-flk(−5.0, −3.5)P-mt),
2 ng of pRL-CMV and various amounts of pSG5 plasmid to keep the
total amount of DNA at 512 ng for each transfection. Luciferase activity
was measured using the Dual-Luciferase® Reporter Assay System
(Promega) and normalized with Renilla Luciferase activity for transfection
efficiency.Fig. 2. Deletion analysis of the flk1 regulatory region identifies a highly conserved el
deletion constructs of flk1-GFP reporter. Linearized DNA of each construct was injec
embryos was analyzed after 1 day of development. The transient endothelial expressio
a minus (no detectable endothelial expression) to the right of the line representing eac
expression in endothelial cells of 1-day-old embryos injected with flk(−6.4)-GFP (
(−5.0, −3.5/−1.5)-GFP (F) or flk(−4.3, −3.5/−1.5)-GFP (G).Quantitative RT-PCR
Total RNA was extracted from the un-injected control and 100 pg FoxH1
mRNA-injected embryos at the 18-somite stage using RNAwiz (Ambion) and
the first strand cDNA was synthesized using the SuperScript™ first-strand
synthesis system for RT-PCR (Invitrogen). The relative flk1 expression level
was determined by quantitative PCR using DNA Engine Opticon (MJ
Research). β-actin was used as the internal control for normalization. Primers
used: β-actin forward primer, 5′-CTGTCTTCCCATCCATCGTGGGTC-3′; β-
actin reverse primer, 5′-CTCCATATCATCCCAGTTGGTGACA-3′. flk1 for-
ward primer, 5′-GAGAACGGAACCAACAAGATCCACGAG-3′; flk1 reverse
primer, 5′-CCCTCCAGCAGAACTGACTCCTTAC-3′.
Results and discussion
Identification of an endothelial-specific regulatory element of
the flk1 gene
As the first step toward understanding the regulation of flk1
at the transcriptional level, we isolated an ∼6.4-kb DNA
fragment upstream of the translation initiation site of theement that is necessary for endothelial expression. (A) Schematic diagram of the
ted in wild type zebrafish embryos at the 1-cell stage. GFP expression in injected
n directed by each construct is summarized by a plus (endothelial expression) or
h construct. * marks the transcription initiation site of flk1. (B–G) Transient GFP
B), flk(−5.0)-GFP (C), flk(−4.3)-GFP (D), flk(−5.0, −4.3/−1.5)-GFP (E), flk
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construct, flk(−6.4)-GFP, using this 6.4 kb flk1 upstream DNA
fragment to drive GFP expression.
We generated a transgenic zebrafish line TG(flk1:GFP)la116
that carries a germline-integrated flk(−6.4)-GFP transgene and
found that the GFP expression pattern in TG(flk1:GFP)la116
resembled the endogenous flk1 expression pattern. GFP signals
can be observed in TG(flk1:GFP)la116 embryos as early as the
6-somite stage. At the 8-somite stage, GFP signals are detected
in three patches of cells in TG(flk1:GFP)la116 embryos (Figs.
1B, D), similar to the endogenous flk1 expression pattern
(Figs. 1A, C). The similarities between the endogenous flk1
expression pattern and GFP expression pattern in TG(flk1:
GFP)la116 embryos continue as development proceeds. GFP
expression is detected in the dorsal aorta, posterior cardinal
vein, intersomitic vessels and endothelial cells in the brain by
24 h post-fertilization (hpf), and in paired dorsal longitudinal
anastomotic vessels (DLAV) by 48 hpf (Figs. 1E–L). By
3 days of development, endothelial cells in the pharyngeal
arches can be clearly detected by GFP expression in TG(flk1:
GFP)la116 embryos (Fig. 1M). This pattern is distinct from that
observed in TG(fli:EGFP)y1 embryos where both the aortic
arches and the mesenchyme of the forming jaw are GFP
positive (Lawson and Weinstein, 2002). Furthermore, the GFP
expression patterns in TG(flk1:GFP)la116 embryos are consis-
tent with the other two independent transgenic lines using the
same 6.4-kb regulatory element (Cross et al., 2003; Beis et al.,
2005; Jin et al., 2005), indicating that the ∼6.4-kb flk1 up-
stream regulatory element is sufficient to drive gene expression
in endothelial cells and that this endothelial expression pattern
is not an artifact of the integration site of the flk(−6.4)-GFP
transgene.
In addition, we found that while the spatial GFP expression
of TG(flk1:GFP)la116 resembles the endogenous flk1 expression
pattern revealed by the in situ hybridization, the temporal
regulation is different. In zebrafish, the expression of flk1 in
endothelial cells is greatly reduced after 3 days of development
(Fouquet et al., 1997; Liao et al., 1997). However, theFig. 3. Transgenic analysis of the flk1 regulatory region identifies a 1.5-kb minimal en
trunk (B) of 2-day-old TG(flk1:GFP)la116 embryos. (C–D) GFP expression patterns
transgene resembles the patterns observed in TG(flk1:GFP)la116. (E–F) Embryos ca
endothelial cells (arrowhead) as well as neural tissues. Arrows point to GFP positiveendothelial GFP signal remains strong in TG(flk1:GFP)la116
throughout embryogenesis and persists into adulthood (Figs.
1N–P), indicating that the regulatory sequences responsible
for down-regulating flk1 is not present or is not intact in the
∼6.4-kb flk1 upstream DNA fragment.
Identification of the minimal flk1 endothelial enhancer
To identify critical cis-regulatory elements for flk1 expres-
sion in endothelial cells within the ∼6.4-kb flk1 regulatory
element, we made a series of deletion variants of flk(−6.4)-GFP.
The flk(−5.7)-GFP, flk(−5.0)-GFP, flk(−4.3)-GFP, flk(−3.5)-
GFP and flk(−1.5)-GFP deletion variants have the GFP reporter
gene under the control of the ∼5.7-kb, 5.0-kb, 4.3-kb, 3.5-kb
and 1.5-kb DNA fragments upstream from the flk1 translation
initiation site, respectively. We injected these deletion con-
structs into zebrafish embryos at the 1-cell stage to evaluate the
ability of these constructs to drive GFP expression in the
zebrafish embryonic vasculature. We found that of the 196
embryos injected with flk(−6.4)-GFP, 158 (80.6%) had strong
GFP expression in endothelial cells (Figs. 2A, B). Similar
results were observed in embryos injected with flk(−5.7)-GFP,
flk(−5.0)-GFP and flk(−4.3)-GFP (52.0%, n=125, 52.4%,
n=145 and 51%, n=200, respectively) (Figs. 2A, C, D).
However, none of the embryos injected with the flk(−3.5)-GFP
or flk(−1.5)-GFP constructs had GFP expression in endothelial
cells (n=181 and 130, respectively) (Fig. 2A). These data
suggest that critical regulatory elements for flk1 endothelial
expression are located at least 3.5 kb upstream of the flk1
translational initiation site.
Since flk(−4.3)-GFP was capable of driving GFP expression
in endothelial cells but flk(−3.5)-GFP could not, we focused
our analysis on the region of −4353 to −3543 upstream of flk1.
We did not detect any GFP expression in embryos injected with
the flk(−4.3, −3.5)-GFP construct, indicating that this fragment
alone is not sufficient to drive gene expression in vivo (Fig. 2A).
One possible cause is that this construct lacks a functional
promoter. The TATA box and the predicted transcriptionaldothelial specific enhancer. (A–B) GFP expression patterns in the brain (A) and
of 2-day-old embryos carrying germ line integrated flk(−5.0, −3.5/−1.5)-GFP
rrying germ line integrated flk(−4.3, −3.5/−1.5)-GFP have GFP expression in
cells in forebrain in panel E and to GFP positive cells in neural tube in panel F.
Fig. 4. Cross-species comparison of flk1 5′-flanking sequences. (A) Sequence of flk1 enhancer from −3990 to −3571. (B) Schematic diagrams of 5′-flanking regions
of zebrafish, mouse and human flk1 genes. Consensus sequences of FoxH1, scl, ets and GATA factor binding sites are highlighted in green, red, yellow and blue,
respectively, in panel A and represented with dots with the same color scheme in panel B. Translation initiation sites are marked by arrows. The hatched bar indicates
the zebrafish flk1 upstream sequence from −5.0 kb to −3.5 kb and the grey bar indicates the region from −5.0 kb to −4.3 kb.
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immediately upstream of the flk1 translation initiation site.
Therefore, we created three additional constructs with various
lengths of flk1 5′ sequences from −5 kb to −3.5 kb fused to flk
(−1.5)-GFP, flk(−5.0, −3.5/−1.5)-GFP, flk(−4.3, −3.5/−1.5)-
GFP and flk(−5.0, −4.3/−1.5)-GFP. We injected these
constructs into wild type zebrafish embryos at the 1-cell stage
and found that while no GFP signals were detected in embryos
injected with flk(−1.5)-GFP or flk(−5.0, −4.3/−1.5)-GFP
(n=130 and n=176, respectively), transient GFP expression
in endothelial cells was driven by flk(−5.0, −3.5/−1.5)-GFP
and flk(−4.3, −3.5/−1.5)-GFP constructs (68.8%, n=218 and
53.9%, n=293, respectively) (Figs. 2A, E–G). These findings
indicate that the DNA fragment of −4353 to −3543 has the
information required to drive flk1 expression in endothelial
cells.
We established stable transgenic lines carrying germline-
integrated flk(−5.0, −3.5/−1.5)-GFP or flk(−4.3, −3.5/−1.5)-
GFP transgenes to analyze their GFP expression patterns in
detail. We found that endothelial cells are marked by GFP
expression in embryos carrying flk(−5.0, −3.5/−1.5)-GFP or flk
(−4.3, −3.5/−1.5)-GFP transgenes, consistent with the findings
obtained from transient expression analysis that sequences from
−4353 to −3543 have all critical information to drive gene
expression in endothelial cells. However, when analyzed
closely, we found that while the GFP expression pattern of flk
(−5.0,−3.5/−1.5)-GFP transgenic embryos is identical to that of
TG(flk1:GFP)la116 embryos, flk(−4.3, −3.5/−1.5)-GFP trans-
genic embryos have GFP expression in the brain, the eyes and
the neural tube in addition to endothelial cells (Fig. 3). These
observations, together with our finding that flk(−5.0, −4.3/
−1.5)-GFP does not drive GFP expression in zebrafish embryos
(Figs. 2A, E), indicate that while the DNA fragment from −4353
to −3543 is sufficient to drive flk1 expression in endothelialcells, sequences from −5045 to −4325 are required to restrict
flk1 gene expression to the endothelial cells.
Conserved regulatory control of flk1
To further investigate regulatory mechanisms of flk1 gene
expression, we searched for transcription factor binding sites in
flk1 upstream sequences from −5045 to −3543. In the region
that is critical for restricting flk1 expression to endothelial cells
(−5043 to −4326), we noted an Ets and a GATA factor
consensus binding site but did not identify binding sites for
other transcription factors with known function in endothelial
gene expression, including FoxH1 (see below) (Fig. 4B).
However, multiple consensus binding sites of transcription
repressors, including five engrailed, three pbx and two brn-3
binding sites, were found in this region. Interestingly, all these
genes are expressed in the brain and the eyes (DeCarvalho et al.,
2004; Erickson et al., 2007), raising a possibility that they are
part of the machinery restricting flk1 expression to endothelial
cells. Further studies on molecular mechanisms by which
−5045 to −4326 influences flk1 gene expression, including the
regulatory effects of engrailed, pbx and brn-3 on flk1, should
provide more insights into flk1 gene regulation.
The flk1 upstream segment from −4353 to −3543 is critical
for driving GFP expression in endothelial cells. In this region,
we found multiple binding sites of scl, Ets and GATA factors.
Interestingly, these transcription binding sites are also present in
the mouse flk1 minimal enhancer and human flk1/KDR
promoter (Patterson et al., 1995; Kappel et al., 2000) (Fig. 4),
suggesting that the regulatory machinery of flk1 gene expres-
sion is conserved from fish to mammals.
In addition to scl, ets and GATA binding sites, there are
three FoxH1/Fast1 binding sites in the flk1 minimal regulatory
element (−4353 to −3543) (Fig. 4). While the role of FoxH1 in
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signaling on the proliferation, differentiation, migration and
permeability of endothelial cells have been well documented in
animal models and in cultured cells (for review, see Goumans
and Mummery, 2000; Goumans et al., 2002), raising a
possibility that flk1 is a target gene of FoxH1-mediated TGFβ
signaling. We therefore investigated whether FoxH1 binding
sites are also present in the regulatory regions of mouse and
human flk1/KDR genes. As illustrated in Fig. 4B, multiple
FoxH1 binding sites are present within a 5-kb region upstream
of the human and mouse flk1 genes, supporting the notion that
FoxH1 is part of flk1 regulatory machinery that is conserved
from fish to mammals.
FoxH1 binds to the flk1 minimal endothelial enhancer in vitro
To explore the possibility that FoxH1 regulates flk1 gene
expression directly, we tested whether FoxH1 could bind to the
consensus FoxH1 binding sites in the flk1 minimal regulatory
element. We performed a gel shift assay using a synthetic
oligonucleotide, flk-FoxH1, corresponding to flk1 upstream
sequences from −3870 to −3844, consisting of one FoxH1
binding site, as a probe. As shown in Fig. 5A, FoxH1 binds to
flk-FoxH1 in vitro and this binding is competed away by
unlabeled probes in a dosage-dependent manner (Fig. 5A). It
was previously shown that a G to C substitution in the FoxH1
binding site consensus sequence abolishes its interaction with
FoxH1 (Chen et al., 1996). We found that flk-FoxH1-mt,Fig. 5. FoxH1 regulates flk1 expression at the level of transcription. (A) FoxH1-GST f
(flk-FoxH1) corresponding to the flk1 enhancer. Unlabeled probe and unlabeled fl
sequences of the FoxH1 binding site were used as competitors in the gel shift assay a
assays were performed at least three times with comparable results. (B) HEK293T
expression vector encoding FoxH1. Values are relative to the luciferase activity of ce
experiments are shown.synthetic oligonucleotides harboring the same G to C mutation
in the consensus sequences of the FoxH1 binding site did not
compete out FoxH1 interaction with the labeled probes (Fig.
5A), indicating that the binding of FoxH1 to the flk1 minimal
endothelial enhancer is sequence specific.
FoxH1 suppresses flk1 gene expression in HEK293T cells
Previous studies show that FoxH1 can function as an
activator as well as a repressor (Labbe et al., 1998; Watanabe
and Whitman, 1999; Osada et al., 2000; Saijoh et al., 2000;
Kofron et al., 2004; Chen et al., 2005). We therefore explored
the regulatory relationship between FoxH1 and flk1 in
HEK293T cells. pGL3-flk(−5.0, −3.5)P is a construct
that uses the flk1 upstream sequences from −5045 to −3543
and a 162-bp flk1 basal promoter to drive luciferase expression.
Co-transfecting pSG5-FoxH1 with pGL3-flk(−5.0, −3.5)P
represses the production of luciferase in a dosage-dependent
manner (p<0.05) (Fig. 5B), demonstrating that FoxH1 func-
tions as a repressor for flk1. To investigate if the repressive
activity of FoxH1 is DNA-binding dependent, we created the
pGL3-flk(−5.0, −3.5)P-mt construct where the Gs in all three
FoxH1 binding sites on the minimal flk1 regulatory element
were substituted with Cs (Chen et al., 1996). HEK293T cells
transfected with pGL3-flk(−5.0, −3.5)P-mt have similar
luciferase activity as those cells transfected with pGL3-flk
(−5.0, −3.5)P, indicating that loss of FoxH1 binding does not
affect the activity of flk1 minimal enhancer. Furthermore, nousion protein were purified and used in a gel shift assay with a radiolabeled probe
k-FoxH1-mt, oligonucleotides carrying a G to C substitution in the consensus
t 50-, 100- or 200-fold molar excess. A representative experiment is shown. All
cells were transiently transfected with the indicated luciferase reporters and an
lls transfected with pGL3-flkP alone. Results of an average of four independent
742 J. Choi et al. / Developmental Biology 304 (2007) 735–744significant difference in luciferase activity was observed when
FoxH1 expression plasmid was cotransfected with pGL3-flk
(−5.0, −3.5)P-mt (Fig. 5B), suggesting that the repressive effect
of FoxH1 on flk1 expression is DNA-binding dependent.
FoxH1 negatively regulates zebrafish vascular formation
We further explored the regulatory effect of FoxH1 on the
formation of the embryonic vascular system in zebrafish. Our
data show that FoxH1 represses the transcription activity of the
flk1 minimal endothelial enhancer in cultured cells. If the same
regulatory relationships were relevant during embryonic
vascular formation, one would expect flk1 expression levels toFig. 6. FoxH1 modulates vascular formation in zebrafish. (A) flk1 is expressed in the d
elevated in MZsur embryos (right). (B) Injection of FoxH1 mRNA disrupts zebrafish
of mRNA encoding the FAST-Eng chimeric protein disrupts vascular formation (right
the 23-somite stage. (D) Injection of mRNA encoding FAST-VP16 chimeric prote
Embryos were analyzed at the 18-somite stage. Arrows point to patches of endothelia
of the un-injected (right), smad2MO and FoxH1 mRNA co-injected (middle) and sma
relative GFP intensities within the region of interests (indicated by the yellow and rbe increased in zebrafish embryos lacking FoxH1 function. The
zebrafish schmalspur (sur) locus encodes FoxH1/Fast1 (Pogoda
et al., 2000; Sirotkin et al., 2000). We analyzed flk1 expression
levels in the maternal-zygotic sur homozygotes (MZsur)
derived from the surty68b allele which carries a point mutation
in the conserved FKH domain (Pogoda et al., 2000). As shown
in Fig. 6A, the flk1 expression levels are indeed moderately
elevated in MZsur embryos, supporting the notion that FoxH1 is
a repressor of flk1. We further analyzed the forced expression
effects of FoxH1 on vascular formation in vivo. Data collected
from three independent experiments showed that 44 out of 73
TG(flk1:GFP)la116 embryos injected 50 pg of FoxH1 mRNA
(60%) and 265 out of 282 TG(flk1:GFP)la116 embryos injectedeveloping vasculature of embryos at 32 hpf (left). The expression level of flk1 is
vascular formation. Embryos were analyzed at the 18-somite stage. (C) Injection
), resembling the phenotype of FoxH1 overexpression. Embryos were analyzed at
in does not disrupt the GFP expression pattern in TG(flk1:GFP)la116 embryos.
l cells missing in FoxH1 or FAST-Eng mRNA-injected embryo. (E) Lateral view
d2MO-injected (left) TG(flk1:GFP)la116 embryos at 24 hpf. (F) Graph represents
ed boxes in panel E).
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endothelial cells (Fig. 6B), suggesting that FoxH1 negatively
regulates vascular formation in zebrafish and that this negative
effect of FoxH1 on zebrafish vascular formation is dose
dependent. Furthermore, we measured relative flk1 gene
expression level in control and FoxH1 mRNA-injected embryos
using quantitative RT-PCR. From two independent experiments
performed in triplicate, we consistently observed that the levels
of flk1 transcripts in those embryos injected with 100 pg of
FoxH1 mRNA were 48% of the levels in un-injected embryos
(standard deviation=4.2%, p<0.001), supporting the notion
that FoxH1 represses flk1 gene expression.
To further confirm that FoxH1 does indeed have a negative
effect on vascular formation, we injected FAST-Eng and FAST-
VP16 mRNA into TG(flk1:GFP)la116 embryos at the 1-cell
stage. FAST-Eng and FAST-VP16 encode proteins that have the
wild type FoxH1 forkhead DNA-binding domain fused to the
transcriptional repressor domain of Engrailed (FAST-Eng) and
the viral transcriptional activator domain of VP16 (FAST-
VP16), respectively (Watanabe and Whitman, 1999). Embryos
injected with 10 pg of FAST-VP16 mRNA died before vascular
formation. We, therefore, focused our analysis on lower levels
of FAST-VP16 injection. None of the 130 embryos that received
4 pg of FAST-VP16 had notable vascular defects (Fig. 6D). On
the other hand, embryos injected with FAST-Eng mRNA
displayed a phenotype resembling that observed in FoxH1
mRNA-injected embryos and this effect was dosage-dependent.
While 43 out of 55 TG(flk1:GFP)la116 embryos injected with
10 pg of mRNA encoding FAST-Eng had missing patches of
endothelial cells, all 36 TG(flk1:GFP)la116 embryos injected
with 25 pg of FAST-Eng mRNA had missing patches of
endothelial cells (Fig. 6C). These data demonstrate that FoxH1
functions as a repressor and has a negative effect on zebrafish
vascular development.
Studies in Xenopus have demonstrated both smad2-depen-
dent and smad2-independent effects of FoxH1 in early
embryogenesis (Kofron et al., 2004). We therefore evaluated
whether the negative effects of FoxH1 on flk1 gene expression
are smad2 dependent. If indeed the negative effects of FoxH1
on flk1 expression and zebrafish vascular formation were
smad2 dependent, one would expect that knocking down smad2
activity could counteract the effects of FoxH1 overexpression.
We found that while TG(flk1:GFP)la116 embryos injected with
0.8 ng of Smad2MO developed normally, the GFP signals in
endothelial cells were brighter than their un-injected siblings
(86%, n=112) and that co-injecting 50 pg of FoxH1 mRNA
with 0.8 ng of smad2MO could suppress the smad2MO induced
elevation of GFP signals (100%, n=102) (Figs. 6E, F). We then
quantified the GFP intensity at selected regions of interest in the
brain and in the trunk using the NIH ImageJ software. As shown
in Figs. 6E and F, while there was no significant difference in
the GFP signals between wild type embryos and embryos co-
injected with smad2MO and FoxH1 mRNA (25 embryos
analyzed from each group, p>0.05), the GFP signals were
increased by 2.84-fold in head blood vessels and 1.78-fold in
the dorsal aorta and posterior cardinal vein of smad2 morphants
when compared to wild type embryos (n=25 for each group,p<0.001). These data support the notion that the effects of
FoxH1 on the developing zebrafish vasculature are smad2-
dependent and indicate that TGFβ signaling plays a role in flk1
gene expression.
The role of FoxH1 in early embryogenesis has been studied
extensively, but its relevance in vascular development has not
been explored. In this report, we provide evidence that FoxH1
binds directly to the flk1 endothelial enhancer and modulates
flk1 expression both in vivo and in cultured cells. We also
show that FoxH1 has a negative effect on blood vessel
formation in developing zebrafish embryos, offering the first
evidence of the role of FoxH1 in patterning embryonic
vasculature. It is interesting to note that TGFβ has both
stimulating and inhibitory effects on endothelial cells (Pepper,
1997; Piek et al., 1999). Recent studies indicate that cellular
effects of TGFβ signaling on endothelial cells are determined
by the selection of downstream pathways (Goumans et al.,
2002). In this model, TGFβ signaling via Alk1/smad1,5,8
pathway induces cell proliferation, differentiation and survival,
whereas the Alk5/smad2,3 pathway which involves FoxH1,
inhibits endothelial cell proliferation and differentiation, and
induces cell death (for review, see Goumans et al., 2003). Our
finding that FoxH1 negatively regulates flk1 gene expression in
a moderate and smad2-dependent manner is consistent with the
negative effect of Alk5-mediated TGFβ signaling on endothe-
lial cells and raises the possibility that the VEGF/flk1 pathway
is a direct target of TGFβ signaling. Detailed investigation of
the regulation of the VEGF pathway by TGFβ/FoxH1 will
deepen our understanding of the interplay of these pathways in
endothelial cells.
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